Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sun-Young Han

5PUBLICATIONS

2CO-AUTHORS

Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Mar 26, 2022

Small Molecule Induced FLT3 Degradation.

Sun-Young Han

|Mar 25, 2022

Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components.

Entaz Bahar, Sun-Young Han, Ji-Ye Kim

|Jul 02, 2021

TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs.

Sun-Young Han

|Jan 09, 2021

Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer.

Hyo Jeong Lee, Pyeonghwa Jeong, Yeongyu Moon

|Sep 15, 2017

Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity.

Hyo Jeong Lee, Bo-Kyoung Kim, Kyoung Bin Yoon

Pageof 1

Frequent Collaborators

1 joint publications

Entaz Bahar

1 joint publications

Hyonok Yoon

Frequent Collaborators

1 joint publications

Entaz Bahar

1 joint publications

Hyonok Yoon

Top Related Videos

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers

Published on : Sep 26, 2019

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on : Sep 19, 2018

See more related videos

Top Related Videos

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers

Published on : Sep 26, 2019

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on : Sep 19, 2018

See more related videos